FDA Clearance Tracker · P150035-S029
AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)
Last checked: Nov 20, 2026Latest source record: Aug 15, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 15, 2025
Approved
Time to decision
30 days
Received Jul 16, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150035-S029
- Device name
- AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Jul 16, 2025
- Decided
- Aug 15, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P150035
Device type
- Device type
- Leadless pacemaker (PNJ)
- Device class
- Class III
- Regulation
- 21 CFR 870.3610
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval of version E of the protocol for the post-approval study (PAS) referenced above
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.